The GP2 Phase III clinical trial poster was presented in person at the 2021 annual San Antonio Breast Cancer Symposium (SABCS).
News
- Greenwich LifeSciences Provides Update on Upcoming Phase III Clinical Trial, FLAMINGO ...
- EnergyFunders Launches Two New Investment Funds Targeting Oil & Gas Projects and ... - ForexTV
SAN ANTONIO, Feb. ... MaxCyte Signs Strategic Platform License with Intima Bioscience to Advance Tumor Infiltrating Lymphocytes Programs.
- What About Women? This Company Targets Female-Focused Cancers - Benzinga
... in postmenopausal patients with progesterone receptor positive early breast cancer at the 2021 San Antonio Breast Cancer Symposium.
- PepsiCo Awards $1.2 Million Grant to the Guadalupe-Blanco River Authority to Replace ...
With several company facilities relying on water from the San Antonio River Basin, we have a tremendous interest to help replenish the water ...
- Positive Phase III Data Lifts Madrigal, Hopes for an Effective NASH Treatment | BioSpace
... M.D., medical director for Pinnacle Clinical Research in San Antonio and principal investigator in the MAESTRO studies said in a statement.